Advertisement

Topics

Clough Harbour & Associates LLP Company Profile

19:11 EDT 24th September 2018 | BioPortfolio

Driving a highway should be like a visit to the symphony,” CHA-founder and highway engineer John Clarkson said famously. He saw how the blacktop’s path could set a cadence, how reaching a hilltop could be a crescendo. John had a passion for engineering like none other.
While the diversity of our services has grown tremendously over the decades, one thing has remained constant. John’s vision - that, if well-designed, even the everyday can be extraordinary – still defines our every project.

Location

III Winners CircleP.O. Box 5269
Albany
New York
12205-0269
United States of America

Contact

Phone: (518) 453-4500
Fax: (518) 458-1735
Email: info@cloughharbour.com


News Articles [245 Associated News Articles listed on BioPortfolio]

Harbour BioMed Collaborates with WuXi Biologic for Supply of Novel Antibody

Harbour BioMed has formed an "initial strategic" collaboration with WuXi Biologics to develop clinical trial supplies of Harbour's leading HCAb antibody. Harbour, headquartered in the Boston area with...

Harbour BioMed, a US-China Company, Closes $85 Million Series B Round

Harbour BioMed completed an $85 million Series B financing, which it will use to advance its pipeline that includes both clinical and discovery stage programs. GIC, Singapore's sovereign wealth fund, ...

Harbour BioMed launches with $50mm Series A round

Harbour BioMed (cancer drug discovery) raised $50mm through its Series A round from Advantech Capital, Legend Capital, and company founders. The company its using its transgenic platforms in the disco...

Building a deeper Harbour

Harbour BioMed plans to build its pipeline through internal discovery and deals following its $85 million series B.

Harbour BioMed gets rights to Glenmark's bispecific antibody

Glenmark Pharmaceuticals SA granted Harbour BioMed exclusive rights to develop and sell its bispecific antibody GBR1302 for solid tumors in Greater China. Harbour BioMed also retains a manufacturing o...

Deal Watch: Harbour Expands Horizons Beyond China

Antibody developer Harbour Biomed signs its first deal for rights outside China in cancer pact with Kelun. Portage buys SalvaRx...   

WuXi Biologics, Harbour BioMed in Strategic Mfg. Alliance

WuXi to support the supply of Harbour's products for clinical trials under IND applications

Harbour BioMed in $350 Million Deal for Sichuan Kelun PD-L1 Candidate

Harbour BioMed acquired global rights (ex-China) to a PD-L1 candidate from Sichuan Kelun-Biotech in a deal worth up to $350 million. Kelun-Biotech is currently testing A167 (KL-A167) in several China ...

Drugs and Medications [205 Associated Drugs and Medications listed on BioPortfolio]

Topcare gas relief [Topco Associates LLC]

Topco Associates LLC. Gas Relief Drug Facts

Topcare antacid calcium [Topco Associates LLC]

Topco Associates LLC. Antacid Calcium Drug Facts

Topcare antacid calcium [Topco Associates LLC]

Topco Associates LLC. Antacid Calcium Drug Facts

Topcare milk of magnesia [Topco Associates LLC]

Topco Associates LLC. Milk of Magnesia Drug Facts

Topcare antacid [Topco Associates LLC]

Topco Associates LLC. Antacid Drug Facts

PubMed Articles [140 Associated PubMed Articles listed on BioPortfolio]

The Government response to the consultation on nursing associates.

Emeritus Professor Alan Glasper, from the University of Southampton, discusses a recently published report from the Government on the response to proposals concerning the regulation of nursing associa...

Cortical associates of emotional reactivity and regulation in childhood stuttering.

This study sought to determine the cortical associates of emotional reactivity and emotion regulation (as indexed by the amplitude of evoked response potentials [ERP]) in young children who do and do ...

B-RCA revealed circulating miR-33a/b associates with serum cholesterol in type 2 diabetes patients at high risk of ASCVD.

Type 2 diabetes (T2D) is a complex metabolic disease with high incidence throughout the world. Dyslipidemia is the leading cause of atherosclerotic cardiovascular diseases (ASCVD) in T2D patients. hsa...

The transcription-repair coupling factor Mfd associates with RNA polymerase in the absence of exogenous damage.

During transcription elongation, bacterial RNA polymerase (RNAP) can pause, backtrack or stall when transcribing template DNA. Stalled transcription elongation complexes at sites of bulky lesions can ...

Variation in Interleukin 6 Receptor Gene Associates with Risk of Crohn's Disease and Ulcerative Colitis.

Interleukin 6 (IL6) is an inflammatory cytokine; signaling via its receptor (IL6R) is believed to contribute to development of inflammatory bowel diseases (IBD). The single nucleotide polymorphism rs2...

Clinical Trials [63 Associated Clinical Trials listed on BioPortfolio]

Frailty and Mortality in Older Old With Severe Aortic Stenosis

BACKGROUND.- The frailty syndrome (FS) associates an increase in morbidity and mortality in the elderly patient. When severe and symptomatic, aortic stenosis (AS) is a disease with poor pr...

GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis

This is a prospective, randomized, multi-center study recruiting patients with an in-stent restenosis in the superficial femoral artery. The safety and efficacity of the Viabahn endoprosth...

Endoscopic Resection of Gastric Subepithelial Masses, EndoResect Study

Gastric subepithelial masses might harbour gastrointestinal stromal tumors, which should get resected because of their malignant potential. To minimize the associated surgical trauma endos...

Tap to "Tap", Pathobiome Associates Health Care

The bacteria live in community and in some cases it is the combination of several microorganisms that facilitates transmission and pathogenicity. The concept of pathobiome follows from thi...

Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial

The study will assess the effectiveness of at-home vs. in-office induction for patients entering buprenorphine maintenance at Associates in Internal Medicine (AIM) primary care clinic.

Companies [760 Associated Companies listed on BioPortfolio]

Clough Harbour & Associates LLP

Driving a highway should be like a visit to the symphony,” CHA-founder and highway engineer John Clarkson said famously. He saw how the blacktop’s path could set a cadence, how reaching a hilltop ...

Harbour BioMed

Harbour BioMed is a global biopharmaceutical company discovering and developing innovative therapeutics for cancer, with a focus on immuno-oncology, and immunological diseases. Th...

Harbour Point Capital

Harbour Point Capital (“HPC”) is an independent private equity firm specializing in healthcare investing. The co-founders of HPC have worked together for eight years ...

Harbour Antibodies BV

Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands)...

TA Associates TA Associates

Founded in 1968, TA Associates is one of the largest and most experienced middle market private equity firms. The firm has invested in over 400 companies and manages more than US ...

More Information about "Clough Harbour & Associates LLP" on BioPortfolio

We have published hundreds of Clough Harbour & Associates LLP news stories on BioPortfolio along with dozens of Clough Harbour & Associates LLP Clinical Trials and PubMed Articles about Clough Harbour & Associates LLP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clough Harbour & Associates LLP Companies in our database. You can also find out about relevant Clough Harbour & Associates LLP Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record